Skip to main content

Advertisement

Log in

Venous thromboembolism prophylaxis in mental health in-patient services: a qualitative study

  • Research Article
  • Published:
International Journal of Clinical Pharmacy Aims and scope Submit manuscript

Abstract

Background Venous thromboembolism (VTE) is an important and potentially preventable cause of morbidity and mortality in hospitalised patients. It is a significant, international patient safety issue affecting medical, surgical and mental health in-patients. There is a paucity of published evidence on the incidence of VTE, and the role of VTE risk-assessment and prophylaxis, in mental healthcare settings. Epidemiological evidence indicates that antipsychotic medications are an independent risk factor for VTE. Objective To explore healthcare practitioners’ experiences and perspectives regarding VTE prophylaxis for in-patients in mental health services in Ireland. Setting This study was conducted in two national teaching hospitals in Dublin, Ireland. Method This experiential, qualitative study was conducted using face-to-face, semi-structured interviews. Purposive sampling was used to allow strategic selection of participants from the pharmacy, medical and nursing disciplines. Data was analysed using inductive thematic analysis. Consolidated criteria for reporting qualitative studies guidelines were used as a reporting framework. Main outcome measure Participants’ views on VTE prophylaxis for mental health in-patients. Results Five key themes were derived: risk factors in mental health, attitudes to risk-assessment, challenges with VTE prophylaxis, lack of awareness, and lack of evidence in mental health. Conclusion The results indicate considerable diversities in perceived risk of VTE, and in experiences with VTE risk-assessment and prophylaxis. VTE risk was considered in practice specifically for immobile, older adults and eating disorder patients on bed rest. Specific research is required to address this area of clinical uncertainty in mental health.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. National Institute for Health and Care Excellence. Venous thromboembolism: reducing the risk for hospitalised patients. Clin Guidel. 2010;92 (updated June 2015). https://www.nice.org.uk/guidance/cg92/resources/venous-thromboembolism-reducing-the-risk-for-patients-in-hospital-pdf-975745995973. Accessed 11 Sept 2017.

  2. Raskob GE, Angchaisuksiri P, Blanco AN, Buller H, Gallus A, Hunt BJ, et al. Thrombosis: a major contributor to global disease burden. Arterioscler Thromb Vasc Biol. 2014;34:2363–71.

    Article  PubMed  CAS  Google Scholar 

  3. Scottish Intercollegiate Guidelines Network. Prevention and management of venous thromboembolism. Natl Clin Guidel. 2010;122 (Updated October 2014). http://www.sign.ac.uk/assets/sign122.pdf. Accessed 11 Sept 2017.

  4. Hippsley-Cox J, Coupland C. Development and validation of risk prediction algorithm (QThrombosis) to estimate future risk of venous thromboembolism: prospective cohort study. BMJ. 2011;343:d4656.

    Article  Google Scholar 

  5. Department of Health UK. Risk assessment for VTE. 2010. http://webarchive.nationalarchives.gov.uk/20130107105354/http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/@ps/documents/digitalasset/dh_113355.pdf. Accessed 11 Sept 2017.

  6. Barbui C, Conti V, Cipriani A. Antipsychotic drug exposure and risk of venous thromboembolism: a systematic review and meta-analysis of observational studies. Drug Saf. 2014;37:79–90.

    Article  PubMed  CAS  Google Scholar 

  7. Masopust J, Maly R, Valis M. risk of venous thromboembolism during treatment with antipsychotic agents. Psychiatry Clin Neurosci. 2012;66:541–52.

    Article  PubMed  CAS  Google Scholar 

  8. Zhang R, Dong L, Shao F, Tan X, Ying K. Antipsychotics and venous thromboembolism risk: a meta-analysis. Pharmacopsychiatry. 2011;44:183–8.

    Article  PubMed  CAS  Google Scholar 

  9. Parker C, Coupland C, Hippisley-Cox J. Antipsychotic drugs and risk of venous thromboembolism: nested case-control study. BMJ. 2010;341:c4245.

    Article  PubMed  Google Scholar 

  10. Hagg S, Bate A, Stahl M, Spigset O. Associations between venous thromboembolism and antipsychotics. A study of the WHO database of adverse drug reactions. Drug Saf. 2008;31(8):685–94.

    Article  PubMed  Google Scholar 

  11. Delluc A, Montavon S, Canceil O, Carpentier M, Nowak E, Mercier B, et al. Incidence of venous thromboembolism in psychiatric units. Thromb Res. 2012;130(6):e283–8. https://doi.org/10.1016/j.thromres.2012.10.002 (Epub 2012 Oct 23).

    Article  PubMed  CAS  Google Scholar 

  12. Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32 item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19:349–57.

    Article  PubMed  Google Scholar 

  13. Braun V, Clarke V. Successful qualitative research, a practical guide for beginners. London: SAGE Publications Ltd; 2013.

    Google Scholar 

  14. Cowen P, Harrison P, Burns T. Shorter oxford textbook of psychiatry. 6th ed. Oxford: Oxford University Press; 2012.

    Book  Google Scholar 

  15. Barbar S, Noventa F, Rossetto V, Ferrari A, Brandolin B, Perlati M, et al. A risk assessment model for the identification of hospitalised medical patients at risk for venous thromboembolism: the Padua prediction score. J Thromb Haemost. 2010;8(11):2450–7. https://doi.org/10.1111/j.1538-7836.2010.04044.x.

    Article  PubMed  CAS  Google Scholar 

  16. Jenkinson J. A critical analysis of VTE prophylaxis in psychiatric patients. Poster presentation. Royal College of Psychiatrists’ International Congress; 2012.

  17. Royal College of Psychiatrists. Whole-person care: from rhetoric to reality. Achieving parity between mental health and physical health. Occasional paper OP88. 2013. http://www.rcpsych.ac.uk/files/pdfversion/OP88xx.pdf. Accessed 11 Sept 2017.

  18. McFarland L, Murray E, Harrison S, Heneghan C, Ward A, Fitzmaurice D, et al. Current practice of venous thromboembolism prevention in acute trusts: a qualitative study. BMJ Open. 2014;4(6):e005074.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  19. Al-Taiar H, Nathoo A, Shaheed S. Physical health and VTE risk assessment audit-mental health division (re-audit). 2013. https://www.nice.org.uk/sharedlearning/physical-health-vte-risk-assessment-audit-mental-health-division-re-audit. Accessed 11 Sept 2017.

  20. Croxford A, Clare A, Mc Curdy K. Introduction of venous thromboembolism prophylaxis protocol for older adult psychiatric patients. BMJ Qual Improv Rep. 2015. https://doi.org/10.1136/bmjquality.u205852.w3226.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Patel R. Venous thromboembolism prophylaxis in mental healthcare: do the benefits outweigh the risks? BJ Psych Bull. 2015;39:61–4.

    Google Scholar 

Download references

Acknowledgements

We acknowledge the contribution of Dr Consilia Walsh, St Vincent’s University Hospital, Dublin to the participant selection and recruitment process. We acknowledge the contribution of participants from both Saint John of God Hospital, and St Vincent’s University Hospital, Dublin.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Audrey Purcell.

Ethics declarations

Funding

None.

Conflicts of interest

No conflict of interest declared for each author and contributor.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (PDF 393 kb)

Supplementary material 2 (DOCX 62 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Purcell, A., Clarke, M. & Maidment, I. Venous thromboembolism prophylaxis in mental health in-patient services: a qualitative study. Int J Clin Pharm 40, 543–549 (2018). https://doi.org/10.1007/s11096-018-0599-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-018-0599-7

Keywords

Navigation